Open original FDA record ↗Recall record
- FDA identifier
- Z-1381-2022
- Company in FDA record
- Ivenix, Inc.
- FDA record creation date
- Jul 13, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Downstream occlusion alarm is sometimes immediately followed by a pump problem alarm.
Source facts
- Action
- On April 22, 2022, the firm notified affected customers of the product issue through a letter titled "Important Safety Update." The firm is working on a software update to correct the issue. It will be available in approximately 60 days. The firm will inform customers when the update is ready to install. As interim corrections, the firm recommends that any pump that is infusing into the downstream access port have an infusion pressure less than 525 mm Hg. Alternatively, the Occlusion Retry Attempts in the Infusate Library Care Profile Pump Setting should be set to 0. Care profile pump settings are described in the Infusate Library and Pump Management Instructions for Use. If you have additional questions, please contact Customer Support: support@ivenix.com or 1-978-775-8100
- Initiated
- 2022-04-22
- Root cause
- Software design
- Terminated
- 2024-05-20
- Distribution
- US Nationwide distribution in the states of NJ and WI.
- Recall number
- Z-1381-2022
- Recall status
- Terminated
- CDRH record ID
- 194113
- FDA record created
- 2022-07-13
- Recall event number
- 90314